Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tretinoin with Chemotherapy in Non-Small Cell Lung Cancer
NCT00005825Phase 2Unknown
- Sponsor
- Raghu Nandan, M.D.
- Start
- Sep 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tretinoin in non-small cell lung cancer (NSCLC), sponsored by Raghu Nandan, M.D. Primary endpoint: Response Rate. Status: unknown.
02
Drugs
tretinoin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00005825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005825.